- Home
- RMCF vs ICU Comparison
RMCF vs ICU Comparison
Compare RMCF & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RMCF | ICU |
|---|---|---|
| Founded | 1981 | 2018 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Specialty Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 14.9M | 13.8M |
| IPO Year | 2024 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RMCF | ICU |
|---|---|---|
| Price | $0.98 | $2.94 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 4.3M | 64.1K |
| Earning Date | 06-16-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 34.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $30,432,352.00 | $1,234,000.00 |
| Revenue This Year | N/A | $53.00 |
| Revenue Next Year | N/A | $50.00 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 814.07 |
| 52 Week Low | $0.66 | $0.22 |
| 52 Week High | $2.99 | $5.38 |
Technical Indicators
Market Signals| Indicator | RMCF | ICU |
|---|---|---|
| Relative Strength Index (RSI) | 43.99 | 34.92 |
| Support Level | $0.84 | $2.21 |
| Resistance Level | $1.19 | $3.50 |
| Average True Range (ATR) | 0.09 | 0.17 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 2.32 | 4.69 |
Price Performance
Historical ComparisonAbout RMCF Rocky Mountain Chocolate Factory Inc.
Rocky Mountain Chocolate Factory Inc operates as a manufacturer of chocolate candies and confectionery products. The company prepares numerous products, including caramel apples in the store. The business activity of the firm functions through Franchising, Manufacturing, Retail Stores, and Others. The company derives maximum revenue through manufacturing activities. The products of the company include varieties of Clusters, Caramels, Creams, Toffees, Mints, and Truffles.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.